Allianz Asset Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-87,367
Closed -$4.67M 2721
2016
Q1
$4.67M Buy
87,367
+2,032
+2% +$150K 0.01% 1471
2015
Q4
$9.61M Buy
85,335
+24,985
+41% +$2.75M 0.01% 1067
2015
Q3
$7.1M Sell
60,350
-14,450
-19% -$1.89M 0.01% 1136
2015
Q2
$5.79M Buy
74,800
+25,431
+52% +$1.67M 0.01% 1335
2015
Q1
$2.86M Sell
49,369
-17,291
-26% -$734K ﹤0.01% 1412
2014
Q4
$2.15M Sell
66,660
-528
-0.8% -$15.8K ﹤0.01% 1524
2014
Q3
$1.64M Sell
67,188
-3,339
-5% -$67.8K ﹤0.01% 1503
2014
Q2
$1.25M Buy
70,527
+23,261
+49% +$374K ﹤0.01% 1335
2014
Q1
$946K Buy
+47,266
New +$916K ﹤0.01% 1416

Other funds holding ANAC

Allianz Asset Management's ANAC Position: Q2 2016 in Review

Allianz Asset Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 87,367 shares — an estimated $4.67M sold.

Allianz Asset Management first reported a position in ANAC in Q1 2014 and held it in 9 quarters. The position peaked at $9.61M in Q4 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • Allianz Asset Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • Allianz Asset Management sold 87,367 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $4.67M.
  • Allianz Asset Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2014 and held it in 9 quarters.
  • Allianz Asset Management's ANACOR PHARMACEUTICALS INC COM position peaked at $9.61M in Q4 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Allianz Asset Management's 13F filing for Q2 2016, filed 12 Aug 2016.